Clinical

Dataset Information

0

Irinotecan in Treating Patients With Metastatic Colorectal Cancer

ABSTRACT: RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of irinotecan in treating patients with metastatic colorectal cancer.

DISEASE(S): Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2003060 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Json Xml

Similar Datasets

Clinical Irinotecan in Treating Patients With Colorectal Cancer
| 2003322 | ecrin-mdr-crc
Clinical Irinotecan in Treating Patients With Advanced Cancer of the Stomach
| 2002715 | ecrin-mdr-crc
Clinical Irinotecan in Treating Patients With Metastatic or Recurrent Colorectal Cancer
| 2002537 | ecrin-mdr-crc
Clinical Amifostine Plus Irinotecan in Treating Patients With Metastatic Colorectal Cancer
| 2002789 | ecrin-mdr-crc
Clinical Irinotecan and Capecitabine in Treating Patients With Solid Tumors
| 2003342 | ecrin-mdr-crc
Clinical Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid Tumors
| 2003528 | ecrin-mdr-crc
Clinical Irinotecan and Cyclosporine in Treating Patients With Metastatic, Advanced or Locally Recurrent Colorectal Cancer
| 2003409 | ecrin-mdr-crc
Clinical Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer
| 2002957 | ecrin-mdr-crc
Clinical Irinotecan With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer
| 2005915 | ecrin-mdr-crc
Clinical Olimersen and Irinotecan in Treating Patients With Metastatic or Recurrent Colorectal Cancer
| 2004017 | ecrin-mdr-crc